News und Analysen

Investing $100 can be a good amount to get started in stocks, especially if you're using a brokerage that charges low commission fees or none at all. And over time, you can steadily grow your

Healthcare stocks, particularly pharmaceutical stocks with solid dividends, make great long-term investments.

In general, the need for healthcare products and services is stable, even during

In the financial coliseum of 2023, we find AT&T (NYSE: T) and its investors locked in a high-stakes bull-versus-bear duel. The telecom giant, a perennial darling for dividend-seekers, has found

Investors in Biogen (NASDAQ: BIIB) got some great news last week as the Food and Drug Administration (FDA) approved the company's Alzheimer's drug Leqembi. But despite the big win, the stock didn't

Make money. That's every investor's goal. How each person chooses to achieve that goal makes the difference in exactly how much money they make and how long it takes to make it.

Some stocks are

Shares of Silk Road Medical (NASDAQ: SILK) were down more than 33% as of 12:30 p.m. on Wednesday after the Centers for Medicare & Medicaid Services (CMS) announced a proposed change that could

The S&P 500 is up 15% this year, and there are many stocks that have been performing much better than that. Shares of Hims & Hers Health (NYSE: HIMS) and Viking Therapeutics (NASDAQ: VKTX) have been

Did you know that if you earned an average of 7% per year, your investment would double in 10 years? That's lower than the S&P 500's long-run average of 10%. Investing in some top growth stocks

High dividend yields are attractive to investors. Who doesn't want a large stream of steady income? However, there's more to it than that, as there is an underlying asset to the dividend that could

Vertex Pharmaceuticals' (NASDAQ: VRTX) stock has climbed nearly 20% so far this year, and for good reason. The biotech company completed a regulatory submission for what may become its next

Novavax (NASDAQ: NVAX) shares soared more than 30% in one trading session this week. That's a huge gain for any stock. But it's particularly impressive for Novavax. The biotech stock has been in the

Shares of telecom giant AT&T (NYSE: T) fell 13.4% in the first half of 2023, according to data from S&P Global Market Intelligence. Over the same time span, the S&P 500 market index gained 15.9%. In

UnitedHealth Group (NYSE: UNH) is the largest private health insurance company in the U.S., with more than 400,000 employees. It pulled in $324.2 billion in revenue last year, making it the largest

Amid last year's difficult market, you may not have put all of your investable money to work -- in which case, you might have cash sitting on the sidelines. This would be the perfect time to deploy

Fool.com contributor Parkev Tatevosian compares Deere (NYSE: DE) and AT&T (NYSE: T) to determine which is the better dividend stock for passive income investors.

*Stock prices used were the

Shares of Novavax (NASDAQ: NVAX) were up more than 24% as of 12:08 p.m. ET on Monday after the biotech company said Friday that Canada will pay $349.6 million for unused COVID-19 shots from the

At any given time, the market may not be appropriately valuing a stock based on the fundamentals of its underlying business. This is because market participants aren't always completely rational

A good measure of a truly great business is that it outperforms the broader market over the long haul. This is because over the long term total returns tend to be more closely aligned with